News & Perspective

Oct 19, 2017

Oct 19, 2017
Ferret

Study details pandemic potential of latest H7N9 flu strains

In a sample from a patient who died, researchers saw signs that the H7N9 virus had started to mutate to a form resistant to Tamiflu.

Sep 08, 2016

Sep 08, 2016

News Scan for Sep 08, 2016

Prize for drug-resistance tests
Anthrax-like illness in Africa
H7N9 vaccine trial results

Sep 24, 2014

Sep 24, 2014

News Scan for Sep 24, 2014

More EV-D68 cases
MERS case definition
Early H7N9 vaccine trials

Jun 17, 2014

Jun 17, 2014

Flu Scan for Jun 17, 2014

H7N9 in China
Low global flu activity
Recombinant flu vaccine contract

Apr 30, 2014

Apr 30, 2014

Flu Scan for Apr 30, 2014

Stop-work order for flu antiviral
H7N9 vaccine phase 1 results

Dec 20, 2013

Dec 20, 2013

Flu Scan for Dec 20, 2013

ECDC weighs H7N9 threat
Firm seeks peramivir approval

Oct 23, 2013

Oct 23, 2013

Flu Scan for Oct 23, 2013

New H7N9 case in China
Flu vaccine capacity building

Oct 01, 2013

Oct 01, 2013
US Capitol building

Fed shutdown affects disease detection, food safety

Response to seasonal flu, H7N9, MERS, and other threats could be markedly diminished.

May 10, 2013

May 10, 2013

Experts offer dim view of potential vaccine response to H7N9

If the H7N9 influenza virus now circulating in China evolves into a pandemic strain, the world is likely to have great difficulty providing adequate supplies of an effective vaccine in time to blunt its impact, according to a viewpoint article by three experts in the Journal of the American Medical Association (JAMA).

Apr 05, 2013

Apr 05, 2013

CDC working on vaccine, tests for novel H7N9 virus

(CIDRAP News) – US health officials said today they are working on a potential vaccine and diagnostic tests for the novel H7N9 influenza strain in China and are warning clinicians to be alert, but they emphasized that they see no signs that the virus is spreading from person to person.

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»